Strategy
Manufacturing
Integrated production capabilities, specialized facilities, and a firm commitment to quality and sustainability.
Private Label Brands: Strategic Partnerships to Maximize Manufacturing and Profitability
In 2025, private label brand partnerships served as a key strategic element in maximizing manufacturing capacity utilization and improving profitability. Through long-term collaborations with major clients, Avalon adopted cooperation models based on joint planning, clear volume commitments, and stable production schedules, contributing to higher production line utilization rates and more efficient distribution of manufacturing workloads.
These partnerships also enabled Avalon to maximize the utilization of fixed costs, improve unit cost efficiency, and achieve stable and scalable margins, while maintaining the highest standards of quality and compliance. This approach underscores the role of Private Label as a value-added partnership, supporting sustainable profitable growth and enhancing manufacturing readiness for future expansion.
Avalon Pharma’s approach in 2025 reflects a practical shift toward more efficient commercial performance, faster execution, and a flexible operational model, supporting sustainable growth and enhancing competitiveness in the medium and long term.
02
Driving Sustainable Growth and Market Leadership
Avalon Pharma’s manufacturing capabilities form a core pillar of its commitment to delivering high-quality pharmaceutical products. Through advanced facilities, robust production capacity, and strict adherence to the highest standards, Avalon ensures it can meet the growing demand from healthcare providers and consumers.
Integrated Manufacturing Capabilities
Avalon Pharma is distinguished by the production of over 300 pharmaceutical SKUs, supported by a robust development portfolio of more than 40 active pharmaceutical ingredients under development. This extensive production scale highlights the company’s pivotal role in the pharmaceutical industry and its ability to deliver innovative solutions across a wide range of therapeutic areas.
pharmaceutical SKUs
active pharmaceutical ingredients in development
million tablets and capsules annually
Annual Production Capacity
Oral solid dosage forms — million units
Liquids — million units
Creams — million units
Disinfectants — million units
03
Specialized Manufacturing Facilities
A network of advanced facilities, each designed to meet specialized healthcare needs.
- 01
Avalon Pharma 1 Focuses on the production of tablets and capsules, nasal sprays, creams, topical solutions, and cosmetic products.
- 02
Avalon Pharma 2 initially operated as a comprehensive R&D center and analytical development laboratory. Later, solid dosage production lines were added with an annual capacity of 272 million tablets, alongside semi-solid preparations with an annual capacity of 22 million units.
- 03
Avalon Pharma 3 is the largest disinfectant manufacturer in Saudi Arabia, also producing sanitizers, mouthwashes, external-use liquids, and large-size hygiene products.
- 04
Avalon Pharma 4 is a future-ready facility designed to manufacture injectable products, oncology drugs, and ophthalmic preparations, enhancing Avalon’s capabilities in specialized healthcare solutions.
Commitment to Sustainability and Compliance
Avalon Pharma maintains strict environmental and regulatory standards, reinforcing its commitment to responsible manufacturing through:
- Obtaining ISO certifications: ISO 14001 for Environmental Management Systems, and ISO 13485 and 9001 for Quality Management Systems.
- Adhering to Good Manufacturing Practices (GMP) to ensure safe and effective production.
- Transitioning from diesel generators to Saudi electrical power, contributing to reduced environmental impact.
- Implementing water and energy conservation strategies, along with safe disposal and recycling of medical products, and establishing emission monitoring and reduction procedures to ensure environmental compliance and achieve sustainability goals.
CertificationISO 14001 CertificationISO 13485 CertificationISO 9001
Expertise in Private Label Manufacturing
As a trusted private label manufacturer, Avalon Pharma collaborates with its clients to deliver high-quality products tailored to their specific requirements. Rigorous testing, approval, and validation processes ensure that these products comply with the highest safety and quality standards.
Advancing Through Research and Development
Innovation is the driving force behind Avalon’s manufacturing success, with the R&D center fostering a culture of exploration and innovation, and supporting product development through advanced analytical expertise and technologies. This focus on continuous improvement reinforces Avalon Pharma’s position as a leader in healthcare manufacturing.
Avalon’s manufacturing excellence not only ensures a stable supply of high-quality products but also underscores its commitment to innovation, sustainability, and meeting the needs of its regional markets.